Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association

by Maxime Teixeira, Razan Sheta, Walid Idi, Abid Oueslati
Published 2021-09-01

Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies

by Emilie Lacombe, Vitaly Khaindrava, Christophe Melon, Abid Oueslati, Lydia Kerkerian-Le Goff, Pascal Salin
Published 2009-10-01

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.

by Abid Oueslati, Blaise Lovisa, John Perrin, Georges Wagnières, Hubert van den Bergh, Yanik Tardy, Hilal A Lashuel
Published 2015-01-01

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates

by Alexander Maxan, Giacomo Sciacca, Melanie Alpaugh, Zhu Tao, Ludivine Breger, Benjamin Dehay, Zhang Ling, Qin Chuan, Giulia Cisbani, Maria Masnata, Shireen Salem, Steve Lacroix, Abid Oueslati, Erwan Bezard, Francesca Cicchetti
Published 2020-07-01

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

by Philippe Gosset, Alexander Maxan, Melanie Alpaugh, Ludivine Breger, Benjamin Dehay, Zhu Tao, Zhang Ling, Chuan Qin, Giulia Cisbani, Nadia Fortin, Jean-Paul G. Vonsattel, Steve Lacroix, Abid Oueslati, Erwan Bezard, Francesca Cicchetti
Published 2020-07-01

Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease

by Stefan Bartl, Abid Oueslati, Amber L. Southwell, Alberto Siddu, Michela Parth, Linda Suzanne David, Alexander Maxan, Nina Salhat, Markus Burkert, Andreas Mairhofer, Theresa Friedrich, Halyna Pankevych, Katja Balazs, Guenther Staffler, Michael R. Hayden, Francesca Cicchetti, Oskar W. Smrzka
Published 2020-07-01